AFLAC

At the KBW Insurance Conference 2026, Aflac presented a strategy of capital discipline, selective growth and operational improvements. The company repositioned roughly 5% of its Japan portfolio, boosting net investment income and reducing valuation risks, while savings and life products and the new reinsurance offering Aflac Re are providing growth. In the US, Aflac is selectively expanding group and direct business as well as dental and vision benefits, but expects significant scale effects only in 2–3 years. AI is expected to deliver efficiency gains, but is not seen as the primary lever to lower expense ratios; the capital position remains comfortably above target levels. » Mere på de.investing.com

Aflac shares fell about 0.6% in premarket trading to $121.02 after the ex-dividend date for the quarterly dividend of $0.61 per share. Additional pressure came from Wolfe Research’s downgrade to “Underperform” with a $103 price target—implying roughly 15% downside—and from a partial share sale by Japan Post Holdings. Analysts point to a slowing core business in Japan, EPS supported by buyback-driven growth, and weak Q2 results, leaving Aflac’s Japan strategy and capital allocation under continued scrutiny. » Mere på de.investing.com

Aflac shares rose to an all-time high of $122.93 and delivered a total return of 22.59% over the past year. Valuation metrics show a P/E ratio of 13.85 and a low PEG of 0.37, while InvestingPro rates the stock slightly above its fair-value estimate. For Q1 2026, Aflac reported revenue of $4.35 billion (expectation $4.18 billion); adjusted EPS was $1.75, just below the $1.80 estimate. The company highlights its strong dividend track record (42 consecutive years of increases) and operational initiatives such as opening an office in South Portland, Maine. » Mere på de.investing.com